Robert Half (RHI) Q1 2026 Earnings Transcript

Robert Half reported Q1 revenue of $1.3 billion, down 4% reported and 6% adjusted year over year, with EPS falling to $0.14 from $0.17 amid a temporary 56% tax rate. Management issued Q2 guidance for revenue of $1.275 billion to $1.375 billion and EPS of $0.20 to $0.30, while announcing $30 million in annualized cost savings from a $5 million Protiviti severance charge. The company highlighted improving contract talent trends, resilient tech consulting demand, and a stronger Q3 outlook, but continued headwinds in U.S. risk and compliance tied to a weaker regulatory environment.

Analysis

The key read-through is not the modest revenue decline; it is that management is actively engineering a reacceleration in earnings before revenue fully recovers. Protiviti’s cost reset effectively converts a regulatory headwind into a margin bridge, and if Q3 really lands with the full benefit of those cuts, the stock should start trading on forward EPS inflection rather than current top-line softness. That makes the next catalyst window the Q2 print/guidance and then any evidence that the cost base has stabilized enough for operating leverage to show through in late summer.

The more interesting second-order effect is competitive: Robert Half is signaling it can hold capacity while demand improves, which means a larger share of incremental volume should drop through without immediate wage inflation. In staffing, that tends to pressure smaller peers first because they cannot match the combination of brand, proprietary matching data, and balance-sheet flexibility; in consulting, the tighter Protiviti posture may actually improve utilization and quote discipline, especially in tech and internal audit where project mix is healthier. The AI narrative is also a subtle positive for RHI because generative AI appears to be increasing applicant noise, which strengthens the value proposition of a curated intermediary instead of weakening it.

The main bear case is that the revenue recovery is still fragile and heavily dependent on decision-time normalization and SMB confidence, both of which can stall quickly if energy prices or geopolitical stress worsen. The regulatory reset in Protiviti is harder to handicap: if the easing in enforcement persists, the company’s high-margin remediation work may never fully return, so the market may need to accept a structurally lower revenue base even as margins recover. That creates a classic setup where the stock can rerate on earnings upgrades in the near term but remain capped unless top-line growth broadens beyond tech consulting and efficiency work.

Key Decisions for Investors

• Long RHI into the next 4-8 weeks on the thesis that Q2 guidance proves conservative and Q3 EPS inflects first; target a move toward the pre-earnings multiple if management sustains 1%-3% contract growth and Protiviti margin expansion. Cut if sequential revenue momentum rolls over for two consecutive monthly updates.
• Buy an at-the-money or slightly in-the-money RHI call spread 2-3 months out to express the Q3 earnings inflection with defined risk; best payoff if the market starts capitalizing forward EPS before the revenue line fully turns positive.
• Pair trade: long RHI / short a more large-cap, acquisition-heavy staffing or consulting peer that is more exposed to federal spending and slower decision cycles; the spread should benefit if RHI’s organic recovery and cost discipline keep outperforming a weaker peer set over the next quarter.
• If already long RHI, hedge with a small short-dated put structure into macro/geopolitical headlines, since the stock’s main downside is a renewed freeze in client decision-making rather than a balance-sheet issue.
• Maintain a watchlist entry point on pullbacks tied to temporary disappointment in perm trends; management’s own comments suggest perm is noisier than contract, so dips on single-month softness are likely better buys than sells.